Canada vs United States of America: Antimicrobial resistance or decreased susceptibiity (DS/R) to
Canada
8.12
in 2022
United States of America
4.1
in 2022
Canada rank
31st
United States of America rank
34th
Antimicrobial resistance or decreased susceptibiity (DS/R) to over time
- Canada
- United States of America
How they compare
Canada currently reports 8.12 against 4.1 in United States of America, a difference of 4.02.
That makes Canada's figure about 2.0 times United States of America's.
Across all 11 years both countries report, Canada has been ahead every year.
Canada ranks 31st and United States of America ranks 34th of 54 countries.
Canada has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Canada | United States of America | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 4.17 | 2.13 | 2.05 | Canada |
| 2020s | 7.11 | 4.95 | 2.16 | Canada |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antimicrobial resistance or decreased susceptibiity (ds/r) to, Canada or United States of America?
- Canada, at 8.12 against 4.1 in United States of America as of 2022.
- What is the difference in antimicrobial resistance or decreased susceptibiity (ds/r) to between Canada and United States of America?
- 4.02, with Canada ahead.
- How many years of comparable data are there for Canada and United States of America?
- 11 years are reported by both, from 2010 to 2022.
- How do Canada and United States of America rank globally for antimicrobial resistance or decreased susceptibiity (ds/r) to?
- Canada ranks 31st and United States of America ranks 34th of 54 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Antimicrobial resistance or decreased susceptibiity (DS/R) to antimicrobials in Neisseria gonorrhoea isolates (WHO-GASP) (proportion). Statizoid refreshes it automatically from the source and publishes the full history for both places.